Mark Newman - Mar 1, 2023 Form 4/A - Amendment Insider Report for Chemours Co (CC)

Role: President and CEO, Director
Signature: /s/ Pauletta Brown, Attorney-in-Fact
Stock symbol: CC
Transactions as of: Mar 1, 2023
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 3/10/2023, 12:56 PM
Date Of Original Report: Mar 3, 2023
Previous filing: Feb 14, 2023
Next filing: Jun 12, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CC	Performance Stock Option (Right to Buy)	Award	$0	+100K		$0.00	100K	Mar 1, 2023	Common Stock	100K	$38.32	Direct	F1, F2, F3

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
F2	The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.
F3	These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.